Skip to content

RCT in breast cancer genetic counselling.

Web-based tailored information and question prompt for enhancing counselee participation and outcome; a RCT in breast cancer genetic counselling.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24382
Enrollment
200
Registered
2007-01-18
Start date
2007-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic counseling Breast cancer Communication web-based tailored info Erfelijkheidsadvisering Borstkanker Communicatie Web-based tailored informatie

Interventions

The information on the website (E-info geneca) is tailored to counselees' personal situation as guided by their answers on our previously developed 'QUOTE geneca' scale. This produces different packag

Sponsors

NIVEL Department of Medical Genetics of the University Medical Centre Utrecht (UMCU)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Counselee for breast cancer genetic counselling; 2. Age 18 or older; 3. Female gender; 4. Having internet access at home.

Exclusion criteria

Exclusion criteria: 1. Age under 18; 2. Male gender; 3. Not having internet access at home.

Design outcomes

Primary

MeasureTime frame
Counselees' participation, i.e. content and amount of questions asked and information received during the visit.

Secondary

MeasureTime frame
1. Realistic expectations; 2. Information recall; 3. Need fulfilment; 4. Satisfaction; 5. Pre-post changes in breast cancer knowledge; 6. Risk perception; 7. Personal control; 8. Cancer worry; 9. (Intended) adherence to screening advices or prophylactic surgery at 12 months; 10. Satisfaction with e-info gene; 11. Anxiety.

Contacts

Public ContactA. Albada

NIVEL (Neterlands Institute for Health Services Research) Postbus 1568

a.albada@nivel.nl(+31) (0)30 272 97 00

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)